ArticleCancers2025

Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer.

Xinyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.